Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks’ gestation: an observational cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks’ gestation: an observational cohort study ; volume:24 ; number:1 ; day:28 ; month:9 ; year:2024 ; pages:1-8 ; date:12.2024
BMC pediatrics ; 24, Heft 1 (28.9.2024), 1-8, 12.2024
- Urheber
-
Notz, Laura
Adams, Mark
Bassler, Dirk
Boos, Vinzenz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-024-05077-3
- URN
-
urn:nbn:de:101:1-2412142101459.398164998166
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Notz, Laura
- Adams, Mark
- Bassler, Dirk
- Boos, Vinzenz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
The first twelve weeks of gestation
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Stillborn twins at 26 weeks of gestation
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
Glucocorticosteroids and bronchopulmonary dysplasia : is epigenetics the missing link?
Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
The first twelve weeks of gestation
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Stillborn twins at 26 weeks of gestation
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
Glucocorticosteroids and bronchopulmonary dysplasia : is epigenetics the missing link?
Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
The first twelve weeks of gestation
Tenascin-C modulates alveolarization in bronchopulmonary dysplasia
Stillborn twins at 26 weeks of gestation
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
The association between βeta 2-microglobulin and bronchopulmonary dysplasia
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies